CA2261151A1 - Transformation de pichia methanolica - Google Patents

Transformation de pichia methanolica

Info

Publication number
CA2261151A1
CA2261151A1 CA002261151A CA2261151A CA2261151A1 CA 2261151 A1 CA2261151 A1 CA 2261151A1 CA 002261151 A CA002261151 A CA 002261151A CA 2261151 A CA2261151 A CA 2261151A CA 2261151 A1 CA2261151 A1 CA 2261151A1
Authority
CA
Canada
Prior art keywords
methanolica
dna molecules
cells
transformation
pichia methanolica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002261151A
Other languages
English (en)
Other versions
CA2261151C (fr
Inventor
Christopher K. Raymond
Susan D. Holderman
Erica Vanaja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2261151A1 publication Critical patent/CA2261151A1/fr
Application granted granted Critical
Publication of CA2261151C publication Critical patent/CA2261151C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002261151A 1996-07-17 1997-07-14 Transformation de pichia methanolica Expired - Fee Related CA2261151C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68350096A 1996-07-17 1996-07-17
US08/683,500 1996-07-17
PCT/US1997/012581 WO1998002565A1 (fr) 1996-07-17 1997-07-14 TRANSFORMATION DE $i(PICHIA METHANOLICA)

Publications (2)

Publication Number Publication Date
CA2261151A1 true CA2261151A1 (fr) 1998-01-22
CA2261151C CA2261151C (fr) 2003-09-16

Family

ID=24744316

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002261151A Expired - Fee Related CA2261151C (fr) 1996-07-17 1997-07-14 Transformation de pichia methanolica

Country Status (5)

Country Link
JP (1) JP2002515746A (fr)
AU (1) AU718510B2 (fr)
CA (1) CA2261151C (fr)
IL (1) IL128073A0 (fr)
WO (1) WO1998002565A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1344320A (zh) 1998-09-23 2002-04-10 津莫吉尼蒂克斯公司 细胞因子受体zalphall
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
CZ303272B6 (cs) 1999-01-07 2012-07-11 Zymogenetics, Inc. Farmaceutický prostredek obsahující fúzní protein, izolovaná molekula polynukleotidu, expresní vektor, kultivovaná bunka, zpusob prípravy polypeptidu a izolovaný polypeptid
CA2366921C (fr) 1999-03-09 2013-12-17 Zymogenetics, Inc. Nouvelle cytokine ligand zalpha11
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
AU3910000A (en) * 1999-03-22 2000-10-09 Zymogenetics Inc. Improved methods for producing proteins in transformed (pichia)
ES2286029T3 (es) 1999-07-07 2007-12-01 Zymogenetics Inc Receptor de citocina humano.
EP1242600B1 (fr) 1999-12-23 2010-03-03 ZymoGenetics, Inc. La cytokine zcyto18
EP2258725A3 (fr) 2000-06-26 2014-09-17 ZymoGenetics, L.L.C. Récepteur de la cytokine zcytor17
CA2438682A1 (fr) 2001-02-20 2002-08-29 Zymogenetics, Inc. Anticorps liant a la fois bcma et taci
ATE542545T1 (de) 2001-05-24 2012-02-15 Zymogenetics Inc Taci-immunoglobulin-fusionsproteine
CN102180944A (zh) 2001-10-10 2011-09-14 诺和诺德公司 肽的重构和糖缀合
ZA200700168B (en) 2001-10-10 2010-02-24 Novo Nordisk As Remodeling and glycoconjugation of peptides
AU2004236174B2 (en) 2001-10-10 2011-06-02 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
JP2005508179A (ja) 2001-11-05 2005-03-31 ザイモジェネティクス，インコーポレイティド Ｉｌ−２１アンタゴニスト
AU2003280410B8 (en) 2002-01-18 2009-04-23 Zymogenetics, Inc. Cytokine receptor zcytor17 multimers
ES2377188T3 (es) 2002-01-18 2012-03-23 Zymogenetics, Inc. Nuevo ligando de citocina ZCYTOR17
CN101676728A (zh) 2002-04-19 2010-03-24 津莫吉尼蒂克斯公司 细胞因子受体
EP2166103B1 (fr) 2004-08-02 2013-05-22 BASF Plant Science GmbH Procédé d'isolation de séquence de terminaison de transcription
AU2006212807A1 (en) 2005-02-08 2006-08-17 Zymogenetics, Inc. Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
EP3683230A1 (fr) 2005-05-12 2020-07-22 ZymoGenetics, Inc. Compositions et procédés pour moduler les réponses immunologiques
JP2009507777A (ja) 2005-08-09 2009-02-26 ザイモジェネティクス，インコーポレイティド ＴＡＣＩ−Ｉｇ融合分子を用いたＢ細胞性腫瘍の処置方法
AR059025A1 (es) 2005-08-09 2008-03-12 Zymogenetics Inc Metodos para el tratamiento y prevencion de proliferacion de celulas anormales utilizando moleculas de fusion taci
AU2006294511B2 (en) 2005-09-28 2011-11-17 Zymogenetics, Inc IL-17A and IL-17F antagonists and methods of using the same
EA015342B1 (ru) 2006-05-15 2011-06-30 Арес Трейдинг С.А. Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig
EP2602263B1 (fr) 2007-11-21 2019-07-17 Roskilde Universitet Polypeptides comprenant une activité de liaison à la glace
CN101903531B (zh) * 2007-12-19 2013-09-18 格利科菲公司 用于蛋白质生产的酵母菌株
NZ587506A (en) 2008-01-25 2012-09-28 Univ Aarhus Selective exosite inhibition of papp-a activity against igfbp-4
EP2379718B2 (fr) 2008-12-16 2020-12-30 Novartis AG Systèmes de présentation de levures
US9771576B2 (en) 2012-02-01 2017-09-26 Synthetic Genomics, Inc. Materials and methods for the synthesis of error-minimized nucleic acid molecules
WO2014202089A2 (fr) 2013-06-18 2014-12-24 Roskilde Universitet Variants de polypeptides antigel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857467A (en) * 1986-07-23 1989-08-15 Phillips Petroleum Company Carbon and energy source markers for transformation of strains of the genes Pichia
EP0889966A1 (fr) * 1995-11-09 1999-01-13 ZymoGenetics, Inc. Compositions et procedes de production de polypeptides heterologues sur pichia methanolica

Also Published As

Publication number Publication date
AU718510B2 (en) 2000-04-13
IL128073A0 (en) 1999-11-30
JP2002515746A (ja) 2002-05-28
WO1998002565A1 (fr) 1998-01-22
CA2261151C (fr) 2003-09-16
AU3803997A (en) 1998-02-09

Similar Documents

Publication Publication Date Title
CA2261151A1 (fr) Transformation de pichia methanolica
EP1672070A3 (fr) Polypeptides secrétés et transmembranaires et acides nucléiques codant pour ceux-ci
EP1683864A3 (fr) Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
WO1999014328A3 (fr) Polypeptides secretes et transmembranaires et acides nucleiques les codant
WO1999028462A3 (fr) Polypeptides et acides nucleiques codant ces derniers
AU3774300A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000032776A3 (fr) Polypeptides secretes et transmembranaires et acides nucleiques les codant
WO2000015796A3 (fr) Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
WO2000036102A3 (fr) Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
EP0760849A4 (fr) Proteines de recombinaison de type augmentant la permeabilite bactericide (bpi) et de type fixant le liposaccharide (lbd), molecules codant pour ces proteines, leurs procedes de production et leurs utilisations
EP1688430A3 (fr) Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
WO2000043419A3 (fr) Proteine de voies d'exocytose et leurs procedes d'utilisation
EP1241179A3 (fr) Protéine semblable à un cornichon et acides nucléiques le codant
EP2050762A3 (fr) Nouvelles polypeptides et acides nucléiques les codant
EP1251139A3 (fr) Protéine semblable à mendin humain et acides nucléiques le codant
EP1702928A3 (fr) Polypeptides secrétées ou transmembranaire, ainsi que les acides nucléiques qui les codent
EP1241186A3 (fr) Protéine gas-6 (growth arrest-specific gene 6) humaine et acides nucléiques le codant
WO1999042586A3 (fr) Proteines exocytotiques, exo 2, exo 2
EP1612220A3 (fr) Transmembranprotéine sécrétée et acides nucléiques l'encodant
EP1247817A3 (fr) Protéine semblable à le CD23 humain et acides nucléiques le codant
EP1241252A3 (fr) Protéine humaine semblable à l'entéropeptidase et acides nucléiques le codant
EP1241180A3 (fr) Protéine semblable à l'antigène A33 humaine et acides nucléiques le codant
EP1241251A3 (fr) Protéine semblable à prostasin et acides nucléiques le codant
EP1241250A3 (fr) Protéine humaine semblable à la déhydrgénase et acides nucléiques le codant

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed